No-Spa Max (Drotaverine Hydrochloride)

Drotaverine selectively blocks phosphodiesterase‑4, which raises intracellular cyclic AMP levels. The increased cAMP reduces calcium entry into smooth‑muscle cells, leading to relaxation of gastrointestinal, uterine and urinary tract muscles and thereby decreasing spasm‑related discomfort.

The appropriate dose of No‑Spa Max is determined by the prescribing healthcare professional based on the patient’s condition, age, weight and overall health. Patients should follow the exact dosing instructions provided by their doctor or pharmacist.

Safety data for drotaverine during pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using No‑Spa Max.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with traditional anticholinergic antispasmodics, drotaverine has a distinct mechanism as a phosphodiesterase‑4 inhibitor, offering smooth‑muscle relaxation without strong anticholinergic effects. This can result in a different side‑effect profile, often with fewer dry‑mouth or urinary‑retention issues.

No‑Spa Max should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in their original packaging, protect them from moisture, excessive heat and direct sunlight to maintain product stability.

No‑Spa Max is taken orally, usually with a glass of water. The tablet should be swallowed whole and not chewed or crushed unless directed otherwise by a healthcare professional.

Serious adverse reactions, though rare, include severe allergic responses such as rash, swelling or breathing difficulty, marked hypotension, cardiac arrhythmias and significant liver enzyme elevations. Patients should seek immediate medical attention if any of these symptoms occur.

Individuals with known hypersensitivity to drotaverine or any excipients in the tablet should not use No‑Spa Max. Caution is also advised for patients with severe liver or kidney impairment, uncontrolled hypertension, or those taking medications that may cause major interactions.